ONWARD Medical N.V. (Private Placement)
Funding Details
- Awarder
- Inbox
- Date Award
- October 24, 2024
- Vertical
- Medical Technology
- Funding URL
- View Funding Page
- Funding Amount:
- $50,000,000
Company Info
- Traction
- Ottobock has acquired approximately 10% of ONWARD Medical's share capital, and the company has extended its cash runway to two years or more.
- Organizations Involved
- Ottobock SE & Co. KGaA
- Company Description
- ONWARD® Medical is a medical technology company creating therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and movement disabilities. The Company has developed ARC Therapy™, which has been awarded ten Breakthrough Device Designations from the US Food and Drug Administration (FDA).
- Market
- Spinal Cord Injury Therapies
- Location
- Eindhoven, Netherlands
- Coinvestors
- Ottobock SE & Co. KGaA